Apr 30, 2020 ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dementia and other neurodegenerative diseases
Apr 15, 2020 ProMIS Neurosciences announces collaboration to develop serological test to assess COVID-19 immunity
Apr 9, 2020 Journal of the American Academy of Neurology Publishes ProMIS Neurosciences’ Abstracts on Novel Antibody Candidates
Feb 26, 2020 ProMIS Neurosciences Initiates Natural History Study of Blood-Based Biomarkers in Alzheimer’s Disease
Feb 25, 2020 ProMIS Neurosciences Announces Gross Proceeds of $1,257,970 Related to the Exercise of Common Stock Warrants
Feb 11, 2020 ProMIS Neurosciences to Participate in Noble Capital Markets 16th Annual Investor Conference